Effect of Laughter Therapy on Surgical Stress, Oxygen Saturation, Pain and Comfort Level
Effect of Laughter Therapy Based on Kolcaba Comfort Theory on Surgical Stress, Oxygen Saturation, Pain and Comfort Level in Bariatric Surgery Patients
1 other identifier
interventional
66
1 country
1
Brief Summary
The aim of this study is to examine the effect of laughter therapy based on Kolcaba comfort theory, on surgical stress, oxygen saturation, pain and comfort level in bariatric surgery patients. The main questions it aims to answer are:
- 1.Is there a significant difference between salivary cortisol levels of patients with and without laughter yoga before surgical intervention?
- 2.Is there a significant difference between the blood glucose levels of patients who were and were not treated with laughter yoga before surgical intervention?
- 3.Is there a significant difference between the mean scores on the perceived stress scale of patients who were and were not treated with laughter yoga before surgical intervention?
- 4.Is there a significant difference between the oxygen saturation levels of patients with and without laughter yoga before surgical intervention?
- 5.Is there a significant difference between the mean scores on the comfort level scale of patients who were and were not treated with laughter yoga before surgical intervention?
- 6.Is there a significant difference between the mean scores on the pain scale of patients who were and were not treated with laughter yoga before surgical intervention?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Jul 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 3, 2022
CompletedFirst Submitted
Initial submission to the registry
June 22, 2023
CompletedFirst Posted
Study publicly available on registry
July 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedJanuary 11, 2024
January 1, 2024
1.2 years
June 22, 2023
January 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (18)
Stress level
with Perceived Stress Scale-14, 0-56 (min-max), higher scores mean worse outcome
before first laughter therapy application
Stress level
with Perceived Stress Scale-14, 0-56 (min-max), higher scores mean worse outcome
after sixth laughter therapy application (preop first day)
Stress level
with Perceived Stress Scale-14, 0-56 (min-max), higher scores mean worse outcome
postop first day
Pain level
with Visual Analog Scale, 0-10 (min-max), higher scores mean worse outcome
before first laughter therapy application
Pain level
with Visual Analog Scale, 0-10 (min-max), higher scores mean worse outcome
after sixth laughter therapy application (preop first day)
Pain level
with Visual Analog Scale, 0-10 (min-max), higher scores mean worse outcome
postop first day
Comfort level
with General Comfort Questionaire, 48-192 (min-max), higher scores mean worse outcome
before first laughter therapy application
Comfort level
with General Comfort Questionaire, 48-192 (min-max), higher scores mean worse outcome
after sixth laughter therapy application (preop first day)
Comfort level
with General Comfort Questionaire, 48-192 (min-max), higher scores mean worse outcome
postop first day
Blood glucose level
with blood glucose meter
before first laughter therapy application
Blood glucose level
with blood glucose meter
after sixth laughter therapy application (preop first day)
Blood glucose level
with blood glucose meter
postop first day
Oxygen Saturation Level
with pulse oximetry
before first laughter therapy application
oxygen saturation level
with pulse oximetry
after sixth laughter therapy application (preop first day)
Oxygen Saturation Level
with pulse oximetry
postop first day
salivary cortisol sample
salivette cortisol
before first laughter therapy application
salivary cortisol sample
salivette cortisol
after sixth laughter therapy application (preop first day)
salivary cortisol sample
salivette cortisol
postop first day
Interventions
The laughter yoga will be applied to experimanetal group. Every laughter yoga practice is 45 minutes long and is planned 3 times a week for a total of 6 sessions. Control group patients will take only routine nursing care.
Eligibility Criteria
You may qualify if:
- Those who can speak and understand Turkish,
- Those who agreed to participate in the study,
- Adult age group between 18 and 60 years old,
- Those with pain intensity \<2 according to the Visual Comparison Scale,
- Those with time and place orientation,
- Those without vision and hearing problems,
- Those who are literate or have literate relatives,
- Those without history of psychiatric illness,
- Those without any history of psychotropic drug use and history,
- Those without previous laughter yoga practice,
- Those with a smartphone/computer/tablet,
- Those who undergone laparoscopic sleeve gastrectomy surgery,
- Those who can attend the trainings at the specified times so that cortisol is not affected by circadian rhythm,
- Those who are able to comply with the collection of saliva samples,
- American Society of Anesthesiologist (ASA) score I, II or III as assessed by physicians
You may not qualify if:
- Those who speak Turkish but cannot understand,
- Those who are under 18 and over 60 years of age,
- Those who are not willing to participate in the study,
- Those diagnosed with psychiatric illness,
- Those with previous laughter yoga practice,
- Those with physical limitations/respiratory problems who cannot perform yoga movements,
- Those who have difficulty in doing breathing exercises due to deviated septum etc,
- Those who have undergone abdominal surgery in the last six months
- Hypothyroidism, hyperaldosteronism, pregnancy, malignancy, congestive heart failure, psychotic disorder, chronic liver failure, uncontrolled hypertension, glaucoma, herniation, nephrotic syndrome, type 2 diabetes mellitus, Patients with a diagnosis of chronic renal failure and continuous use of medication were excluded as salivary cortisol levels may be affected,
- Those with an ASA score of 4,
- Those who don't undergone laparoscopic sleeve gastrectomy surgery,
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Düzce University Research and Application Center
Düzce, Turkey (Türkiye)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
June 22, 2023
First Posted
July 3, 2023
Study Start
July 3, 2022
Primary Completion
September 15, 2023
Study Completion
December 1, 2023
Last Updated
January 11, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share